当前位置： SCI文献检索 > CELL TRANSPLANTATION期刊下所有文献 > Preclinical safety studies on autologous cultured human skin fibroblast transplantation.

Preclinical safety studies on autologous cultured human skin fibroblast transplantation.

Abstract：

:Recently, FDA approved the clinical use of autologous fibroblasts (LAVIV™) for the improvement of nasolabial fold wrinkles in adults. The use of autologous fibroblasts for the augmentation of dermal and subcutaneous defects represents a potentially exciting natural alternative to the use of other filler materials for its long-term corrective ability and absence of allergic adverse effects proved by clinical application. However, compared to the clinical evidence, preclinical studies are far from enough. In this study, human skin-derived fibroblasts were cultured and expanded for both in vitro and in vivo observations. In vitro, the subcultured fibroblasts were divided into two groups. One set of cells underwent cell cycle and karyotype analysis at passages 5 and 10. The second group of cells was cocultured in medium with different concentrations of human skin extract D for the measurement of collagen concentration and cell count. In vivo, the subcultured fibroblasts were injected into nude mice subcutaneously. Biopsies were taken for morphology observation and specific collagen staining at 1, 2, and 3 months after injection. The results in vitro showed no significant differences in cell cycle distribution between passages 5 and 10. Cell proliferation and secretion were inhibited as the concentration of extract D increased. In vivo, the fibroblasts were remarkably denser on the experimental side with no dysplastic cells. Mitotic cells were easily observed at the end of the first month but were rare at the end of the third month. Type III collagen was detected at the end of the first month, while collagen type I was positive at the end of the second month. The content of both collagens increased as time passed. The above results indicated that the use of the autologous fibroblasts was safe, providing a basic support for clinical use of fibroblasts.

journal_name

Cell Transplant

journal_title

Cell transplantation

authors

Zeng W,Zhang S,Liu D,Chai M,Wang J,Zhao Y

doi

10.3727/096368912X659844

subject

Has Abstract

pub_date

2014-01-01 00:00:00

pages

39-49

issue

eissn

0963-6897

issn

1555-3892

pii

ct0814zeng

journal_volume

pub_type

杂志文章

在线工具

Preclinical safety studies on autologous cultured human skin fibroblast transplantation.